ICR-CTSU/2024/10088 | TD 24.08 FAST Forward Boost: A UK-wide inclusive and pragmatic randomised phase 3 trial testing the safety and effectiveness of delivering simultaneous integrated boost radiotherapy (RT) in 1-week compared with the standard 3-week RT schedule in people with early breast cancer (Cat B, In development) (#22)
Michael Jones
1
- Royal Hobart Hospital, Hobart, TASMANIA, Australia
Content is not available at the time of publishing.